Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3450
-0.0160 (-4.43%)
At close: Jun 11, 2026
Biovica International AB Income Statement
Financials in millions SEK. Fiscal year is May - April.
Millions SEK. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
Operating Revenue | 10.9 | 8.62 | 7.29 | 4.96 | 5.04 | 5.64 |
Other Revenue | 0.03 | 0.03 | 0.01 | 0.26 | 0.06 | 1.84 |
| 10.93 | 8.65 | 7.3 | 5.21 | 5.1 | 7.48 | |
Revenue Growth (YoY) | 33.38% | 18.53% | 39.99% | 2.22% | -31.85% | -22.71% |
Cost of Revenue | -0.34 | 0.54 | 0.41 | 0.34 | 0.37 | 0.37 |
Gross Profit | 11.26 | 8.11 | 6.88 | 4.87 | 4.73 | 7.11 |
Selling, General & Admin | 75.2 | 85.63 | 123.52 | 106.69 | 59.35 | 42.55 |
Other Operating Expenses | 1.33 | 1.78 | 1.56 | 0.9 | -0.84 | -1.17 |
Operating Expenses | 84.99 | 96.25 | 134.51 | 115.8 | 64.95 | 47.52 |
Operating Income | -73.73 | -88.14 | -127.63 | -110.92 | -60.22 | -40.41 |
Interest Expense | - | -0.22 | -0.29 | -0.28 | -0.08 | -0.06 |
Interest & Investment Income | 1.28 | 1 | 1.16 | 0.27 | - | 0.86 |
Currency Exchange Gain (Loss) | 1.38 | 1.38 | 2.63 | 0.17 | 0.25 | 0.23 |
Other Non Operating Income (Expenses) | -0.99 | - | - | 0 | - | -0 |
EBT Excluding Unusual Items | -72.05 | -85.98 | -124.14 | -110.76 | -60.04 | -39.39 |
Gain (Loss) on Sale of Assets | - | - | - | 0.08 | 0.05 | 0 |
Pretax Income | -72.05 | -85.98 | -124.14 | -110.68 | -59.99 | -39.39 |
Income Tax Expense | -0.55 | 1.64 | 0.69 | -0.19 | 0.01 | 0.1 |
Net Income | -71.51 | -87.62 | -124.82 | -110.49 | -60 | -39.48 |
Net Income to Common | -71.51 | -87.62 | -124.82 | -110.49 | -60 | -39.48 |
Shares Outstanding (Basic) | 187 | 93 | 58 | 35 | 28 | 28 |
Shares Outstanding (Diluted) | 187 | 93 | 58 | 35 | 28 | 28 |
Shares Change (YoY) | 112.15% | 58.49% | 67.70% | 22.40% | 0.17% | 20.50% |
EPS (Basic) | -0.38 | -0.95 | -2.14 | -3.17 | -2.11 | -1.39 |
EPS (Diluted) | -0.38 | -0.95 | -2.14 | -3.17 | -2.11 | -1.39 |
Free Cash Flow | -64.91 | -85.65 | -114.72 | -95.85 | -52.53 | -34.41 |
Free Cash Flow Per Share | -0.35 | -0.93 | -1.96 | -2.75 | -1.85 | -1.21 |
Gross Margin | 103.09% | 93.81% | 94.34% | 93.47% | 92.72% | 95.09% |
Operating Margin | -674.85% | -1019.33% | -1749.57% | -2128.65% | -1181.21% | -540.24% |
Profit Margin | -654.51% | -1013.35% | -1711.08% | -2120.36% | -1176.99% | -527.85% |
Free Cash Flow Margin | -594.17% | -990.56% | -1572.60% | -1839.30% | -1030.44% | -460.01% |
EBITDA | -73.03 | -87.06 | -126.55 | -109.71 | -59.01 | -38.9 |
D&A For EBITDA | 0.7 | 1.08 | 1.08 | 1.22 | 1.21 | 1.51 |
EBIT | -73.73 | -88.14 | -127.63 | -110.92 | -60.22 | -40.41 |
Revenue as Reported | 12.25 | 10.96 | 8.3 | 5.7 | 6.3 | 8.88 |